4,4'-dimethoxy-[1,1'-biphenyl]-2-carboxylic acid methyl ester | 185992-69-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4,4'-dimethoxy-[1,1'-biphenyl]-2-carboxylic acid methyl ester
• 英文别名: methyl 4,4'-dimethoxy-[1,1'-biphenyl]-2-carboxylate；4,4'-Dimethoxy-biphenyl-2-carboxylic acid, methyl ester；methyl 5-methoxy-2-(4-methoxyphenyl)benzoate
• CAS: 185992-69-2
• 化学式: C₁₆H₁₆O₄
• 分子量: 272.301
• InChiKey: GIESQPOZLGLUIL-UHFFFAOYSA-N

物化性质

• 熔点：
  55-56 °C
• 沸点：
  421.3±45.0 °C(Predicted)
• 密度：
  1.131±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  20
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.19
• 拓扑面积：
  44.8
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  4,4'-dimethoxy-[1,1'-biphenyl]-2-carboxylic acid methyl ester 在 sodium hydroxide 、 氯化亚砜 、 sodium hydride 作用下， 以 四氢呋喃 、 乙醇 为溶剂， 反应 22.25h， 生成 (2,7-dimethoxy-9H-fluoren-9-ylidene)acetonitrile
  参考文献：
  名称：

  Chronobiotic activity of N-[2-(2,7-dimethoxyfluoren-9-yl)ethyl]-propanamide. Synthesis and melatonergic pharmacology of fluoren-9-ylethyl amides

  摘要：

  A series of fluoren-9-yl ethyl amides (2) were synthesized and evaluated for human melatonin MT1 and MT2 receptor binding. N-[2-(2,7-dimethoxyfluoren-9-yl)ethyl]propanamide (2b) was selected and evaluated in functional assays measuring intrinsic activity at the human MT1 and MT2 receptors and demonstrated full agonism at both receptors. The chronobiotic properties of 2b were demonstrated in both acute and chronic rat models where 2b produced an acute phase advance of 32 min at 1 mg/kg and chronically entrained free-running rats with a mean effective dose of 0.23 mg/kg. Compound 2b is significantly less efficacious than melatonin in constricting human coronary artery. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2004.07.002
• 作为产物：
  描述：

  2-溴-5-甲氧基苯甲酸 、 alkaline earth salt of/the/ methylsulfuric acid 在 tris-(dibenzylideneacetone)dipalladium(0) sodium carbonate 作用下， 以 乙二醇二甲醚 、 水 为溶剂， 反应 16.0h， 生成 4,4'-dimethoxy-[1,1'-biphenyl]-2-carboxylic acid methyl ester
  参考文献：
  名称：

  Chronobiotic activity of N-[2-(2,7-dimethoxyfluoren-9-yl)ethyl]-propanamide. Synthesis and melatonergic pharmacology of fluoren-9-ylethyl amides

  摘要：

  A series of fluoren-9-yl ethyl amides (2) were synthesized and evaluated for human melatonin MT1 and MT2 receptor binding. N-[2-(2,7-dimethoxyfluoren-9-yl)ethyl]propanamide (2b) was selected and evaluated in functional assays measuring intrinsic activity at the human MT1 and MT2 receptors and demonstrated full agonism at both receptors. The chronobiotic properties of 2b were demonstrated in both acute and chronic rat models where 2b produced an acute phase advance of 32 min at 1 mg/kg and chronically entrained free-running rats with a mean effective dose of 0.23 mg/kg. Compound 2b is significantly less efficacious than melatonin in constricting human coronary artery. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2004.07.002

文献信息

• Ruthenium(II)-catalyzed Arylation of <i>ortho</i>-C–H Bonds in 2-Aroyl-imidazoles with Aryl Halides
  作者：Chen-an Wang、Naoto Chatani

  DOI：10.1246/cl.200886

  日期：2021.4.5

  The ruthenium(II)-catalyzed ortho-C−H arylation of 2-aroyl-imidazoles with aryl bromides and chloride is reported. An imidazole ring functions both as a masked ester and a directing group for C−H activation. A variety of functional groups are tolerated under the reaction conditions. The arylated final products could be easily converted into the corresponding esters and amide.

  报道了钌（II）催化的2-芳酰基咪唑与芳基溴化物和氯化物的邻位CH芳基化反应。咪唑环既起掩蔽酯的作用，又起CH活化的指导基团的作用。在反应条件下可以耐受多种官能团。芳基化的最终产物可以容易地转化成相应的酯和酰胺。
• Chronobiotic activity of N-[2-(2,7-dimethoxyfluoren-9-yl)ethyl]-propanamide. Synthesis and melatonergic pharmacology of fluoren-9-ylethyl amides
  作者：James R. Epperson、Marc A. Bruce、John D. Catt、Jeffrey A. Deskus、Donald B. Hodges、George N. Karageorge、Daniel J. Keavy、Cathy D. Mahle、Ronald J. Mattson、Astrid A. Ortiz、Michael F. Parker、Katherine S. Takaki、Brett T. Watson、Joseph P.Yevich

  DOI：10.1016/j.bmc.2004.07.002

  日期：2004.9

  A series of fluoren-9-yl ethyl amides (2) were synthesized and evaluated for human melatonin MT1 and MT2 receptor binding. N-[2-(2,7-dimethoxyfluoren-9-yl)ethyl]propanamide (2b) was selected and evaluated in functional assays measuring intrinsic activity at the human MT1 and MT2 receptors and demonstrated full agonism at both receptors. The chronobiotic properties of 2b were demonstrated in both acute and chronic rat models where 2b produced an acute phase advance of 32 min at 1 mg/kg and chronically entrained free-running rats with a mean effective dose of 0.23 mg/kg. Compound 2b is significantly less efficacious than melatonin in constricting human coronary artery. (C) 2004 Elsevier Ltd. All rights reserved.